206 related articles for article (PubMed ID: 36230952)
21. Induced Pluripotent Stem Cell-Derived Dopaminergic Neurons from Familial Parkinson's Disease Patients Display α-Synuclein Pathology and Abnormal Mitochondrial Morphology.
Diao X; Wang F; Becerra-Calixto A; Soto C; Mukherjee A
Cells; 2021 Sep; 10(9):. PubMed ID: 34572052
[TBL] [Abstract][Full Text] [Related]
22. Benzo(a)pyrene exposure in utero exacerbates Parkinson's Disease (PD)-like α-synucleinopathy in A53T human alpha-synuclein transgenic mice.
Xu W; Qi Y; Gao Y; Quan H; Li Q; Zhou H; Huang J
Toxicol Appl Pharmacol; 2021 Sep; 427():115658. PubMed ID: 34332006
[TBL] [Abstract][Full Text] [Related]
23. Genetic Deletion of Thorase Causes Purkinje Cell Loss and Impaired Motor Coordination Behavior.
Li C; Zhang H; Tong K; Cai M; Gao F; Yang J; Xu Y; Wang H; Chen H; Hu Y; He W; Zhang J
Cells; 2023 Aug; 12(16):. PubMed ID: 37626842
[TBL] [Abstract][Full Text] [Related]
24. Alpha-Synuclein transgenic mice, h-α-SynL62, display α-Syn aggregation and a dopaminergic phenotype reminiscent of Parkinson's disease.
Frahm S; Melis V; Horsley D; Rickard JE; Riedel G; Fadda P; Scherma M; Harrington CR; Wischik CM; Theuring F; Schwab K
Behav Brain Res; 2018 Feb; 339():153-168. PubMed ID: 29180135
[TBL] [Abstract][Full Text] [Related]
25. Thorase variants are associated with defects in glutamatergic neurotransmission that can be rescued by Perampanel.
Umanah GKE; Pignatelli M; Yin X; Chen R; Crawford J; Neifert S; Scarffe L; Behensky AA; Guiberson N; Chang M; Ma E; Kim JW; Castro CC; Mao X; Chen L; Andrabi SA; Pletnikov MV; Pulver AE; Avramopoulos D; Bonci A; Valle D; Dawson TM; Dawson VL
Sci Transl Med; 2017 Dec; 9(420):. PubMed ID: 29237760
[TBL] [Abstract][Full Text] [Related]
26. SARS-CoV-2 Spike Protein S1 Domain Accelerates α-Synuclein Phosphorylation and Aggregation in Cellular Models of Synucleinopathy.
Wang J; Dai L; Deng M; Xiao T; Zhang Z; Zhang Z
Mol Neurobiol; 2024 Apr; 61(4):2446-2458. PubMed ID: 37897633
[TBL] [Abstract][Full Text] [Related]
27. α-Synucleinopathy associated c-Abl activation causes p53-dependent autophagy impairment.
Karim MR; Liao EE; Kim J; Meints J; Martinez HM; Pletnikova O; Troncoso JC; Lee MK
Mol Neurodegener; 2020 Apr; 15(1):27. PubMed ID: 32299471
[TBL] [Abstract][Full Text] [Related]
28. The involvement of α-synucleinopathy in the disruption of microglial homeostasis contributes to the pathogenesis of Parkinson's disease.
Miao Y; Meng H
Cell Commun Signal; 2024 Jan; 22(1):31. PubMed ID: 38216911
[TBL] [Abstract][Full Text] [Related]
29. LETC inhibits α-Syn aggregation and ameliorates motor deficiencies in the L62 mouse model of synucleinopathy.
Schwab K; Frahm S; Magbagbeolu M; Horsley D; Goatman EA; Melis V; Theuring F; Ishaq A; Storey JMD; Harrington CR; Wischik CM; Riedel G
Eur J Pharmacol; 2024 May; 970():176505. PubMed ID: 38503400
[TBL] [Abstract][Full Text] [Related]
30. Fasudil Promotes α-Synuclein Clearance in an AAV-Mediated α-Synuclein Rat Model of Parkinson's Disease by Autophagy Activation.
Yang YJ; Bu LL; Shen C; Ge JJ; He SJ; Yu HL; Tang YL; Jue Z; Sun YM; Yu WB; Zuo CT; Wu JJ; Wang J; Liu FT
J Parkinsons Dis; 2020; 10(3):969-979. PubMed ID: 32568105
[TBL] [Abstract][Full Text] [Related]
31. Conditional expression of Parkinson's disease-related mutant α-synuclein in the midbrain dopaminergic neurons causes progressive neurodegeneration and degradation of transcription factor nuclear receptor related 1.
Lin X; Parisiadou L; Sgobio C; Liu G; Yu J; Sun L; Shim H; Gu XL; Luo J; Long CX; Ding J; Mateo Y; Sullivan PH; Wu LG; Goldstein DS; Lovinger D; Cai H
J Neurosci; 2012 Jul; 32(27):9248-64. PubMed ID: 22764233
[TBL] [Abstract][Full Text] [Related]
32. PTEN-Induced Putative Kinase 1 Dysfunction Accelerates Synucleinopathy.
Nguyen TT; Kim YJ; Lai TT; Nguyen PT; Koh YH; Nguyen LTN; Ma HI; Kim YE
J Parkinsons Dis; 2022; 12(4):1201-1217. PubMed ID: 35253778
[TBL] [Abstract][Full Text] [Related]
33. A homozygous ATAD1 mutation impairs postsynaptic AMPA receptor trafficking and causes a lethal encephalopathy.
Piard J; Umanah GKE; Harms FL; Abalde-Atristain L; Amram D; Chang M; Chen R; Alawi M; Salpietro V; Rees MI; Chung SK; Houlden H; Verloes A; Dawson TM; Dawson VL; Van Maldergem L; Kutsche K
Brain; 2018 Mar; 141(3):651-661. PubMed ID: 29390050
[TBL] [Abstract][Full Text] [Related]
34. Age-dependent neurodegeneration and neuroinflammation in a genetic A30P/A53T double-mutated α-synuclein mouse model of Parkinson's disease.
Rauschenberger L; Behnke J; Grotemeyer A; Knorr S; Volkmann J; Ip CW
Neurobiol Dis; 2022 Sep; 171():105798. PubMed ID: 35750147
[TBL] [Abstract][Full Text] [Related]
35. Alpha-synucleinopathy reduces NMNAT3 protein levels and neurite formation that can be rescued by targeting the NAD+ pathway.
Parsons RB; Kocinaj A; Ruiz Pulido G; Prendergast SA; Parsons AE; Facey PD; Hirth F
Hum Mol Genet; 2022 Aug; 31(17):2918-2933. PubMed ID: 35397003
[TBL] [Abstract][Full Text] [Related]
36. The deglycase activity of DJ-1 mitigates α-synuclein glycation and aggregation in dopaminergic cells: Role of oxidative stress mediated downregulation of DJ-1 in Parkinson's disease.
Sharma N; Rao SP; Kalivendi SV
Free Radic Biol Med; 2019 May; 135():28-37. PubMed ID: 30796974
[TBL] [Abstract][Full Text] [Related]
37. The prion-like spreading of α-synuclein: From in vitro to in vivo models of Parkinson's disease.
Vargas JY; Grudina C; Zurzolo C
Ageing Res Rev; 2019 Mar; 50():89-101. PubMed ID: 30690184
[TBL] [Abstract][Full Text] [Related]
38. Time course and magnitude of alpha-synuclein inclusion formation and nigrostriatal degeneration in the rat model of synucleinopathy triggered by intrastriatal α-synuclein preformed fibrils.
Patterson JR; Duffy MF; Kemp CJ; Howe JW; Collier TJ; Stoll AC; Miller KM; Patel P; Levine N; Moore DJ; Luk KC; Fleming SM; Kanaan NM; Paumier KL; El-Agnaf OMA; Sortwell CE
Neurobiol Dis; 2019 Oct; 130():104525. PubMed ID: 31276792
[TBL] [Abstract][Full Text] [Related]
39. Synthetic alpha-synuclein fibrils cause mitochondrial impairment and selective dopamine neurodegeneration in part via iNOS-mediated nitric oxide production.
Tapias V; Hu X; Luk KC; Sanders LH; Lee VM; Greenamyre JT
Cell Mol Life Sci; 2017 Aug; 74(15):2851-2874. PubMed ID: 28534083
[TBL] [Abstract][Full Text] [Related]
40. Fasudil attenuates aggregation of α-synuclein in models of Parkinson's disease.
Tatenhorst L; Eckermann K; Dambeck V; Fonseca-Ornelas L; Walle H; Lopes da Fonseca T; Koch JC; Becker S; Tönges L; Bähr M; Outeiro TF; Zweckstetter M; Lingor P
Acta Neuropathol Commun; 2016 Apr; 4():39. PubMed ID: 27101974
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
